We assessed the IgG levels anti-diphtheria (D-Ab) and T cell counts (CD4+ and CD8+) in HIV-1 infected subjects undergoing or not highly active antiretroviral therapy (HAART). Approximately 70% of all HIV-1 patients were unprotected against diphtheria. There were no differences in D-Ab according to CD4 counts.
Human immunodeficiency virus-1 (HIV-1) infection leads
to a progressive loss of immune functions involving both T and B lymphocytes (7, 9) . Phenotypic and functional alterations of memory B cells are only partially recovered upon highly active antiretroviral therapy (HAART) (11) . Serum antibodies against measles, tetanus toxin, and HIV-1 antigens are significantly reduced in patients with low memory B-cells (2) .
The Brazilian Immunization Program provides special recommendations and offers free immunization for HIV-1 infected patients (8) , but this recommendation is not regularly enforced (3) . Accordingly, HIV-1-infected patients should be vaccinated against diphtheria/tetanus, pneumococcal disease, influenza, and hepatitis (8) .
Adequate immunization against diphtheria/tetanus consists of receiving 3 injections at 2, 4 and 6 months of age followed by booster doses every 10 years (8) . Several studies have shown that healthy adult populations may not be fully protected against diphtheria (1, 5, 6) . A considerable proportion of susceptible adults to diphtheria were formerly observed in different healthy population of Rio de Janeiro, Brazil. Diphtheria toxin IgG levels in a group of Brazilian blood donors showed that a greater percentage (71%) of young military (18 to 30 years) was protected when compared to civilians (54%) of the same age group. These differences were possibly due to a higher rate of booster vaccination in young military group compared to civilians (1, 10) .
In the present study we assessed the immune status concerning diphtheria in civilian or military HIV-1 infected subjects undergoing or not HAART. The levels CD4 and CD8
T lymphocytes subsets were also evaluated. The ELISA results were expressed as geometric mean (geomean) in attempt to give a normal distribution of data allowing the use of standard statistical tests. The levels of significance of the differences between means were examined by the Unpaired t test (parametric test). The Mann-Whitney test was used for data that did not follow the normal distribution.
Statistical differences between proportion values were evaluated by the Chi Square test. These analyses were performed with GraphPad-Prism software, version 4.02 and EpiInfo version 3.5.1. P<0.05 was taken as significant. Table 1 shows the distribution of IgG anti-diphtheria toxin levels in military and civilian individuals classified by age.
Four (3.8%) military had less than 0.1 IU/ml (unprotected) of
IgG anti-diphtheria toxin and were not included in Table 1 .
Depending on the age group, 25 to 39% of civilians and military were considered to be protected (IgG levels > 1 IU/ml) (data not shown). These data suggest that the number of T lymphocyte subsets does not correlate significantly with lymphocyte function as previously described elsewhere (7).
In spite of the fact that the sample size of untreated patients was small (n = 18) compared to HAART-treated patients (n = 85), data in Table 2 showed that untreated HIV-1 patients had higher (P < 0.05) IgG anti-diphtheria levels (geomean of 0.62 IU/ml) and viral load (log mean of 3.9) compared with HAART-treated patients (geomean of 0.39 IU/ml) and log mean viral load of 2.5. About 26% of HAARTpatients had protective levels of antibodies against diphtheria toxin (> 1.0 IU/ml) compared to 39% of the untreated patients (P>0.05). Comparing with previous published data (12), untreated patients had a similar antibody response to diphtheria toxin to civilian blood donors from the IBEX (geomean of 0.55 Diphtheria Antibodies and T lymphocyte Counts IU/ml). In contrast, HAART-patients had a significant lower specific IgG levels compared with IBEX blood donors, suggesting the persistence of B and/or T cell deficiency despite the specific treatment to HIV-1 infection. There were no significant differences of CD4 or CD8 counts and CD4:CD8 ratio between patients, whether or not undergoing HAART (Table 2) . 
